[vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]
Published on February 26, 2021
Dr. Sudhir Diwan discusses regenerative medicine and moving beyond platelet rich plasma (PRP) and stem cells at the NYSIPP/NJSIPP Symposium. He also discusses epigenetics and how these processes relate to pain. Micro RNAs, growth factors, and exosomes may also play a greater role in the future. Stem cells therapy for pain injuries is at an interesting juncture, but only time will tell how they will ultimately be used in the clinic.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]
[/vc_column_text][/vc_column][/vc_row]


